0001209191-19-040985.txt : 20190703
0001209191-19-040985.hdr.sgml : 20190703
20190703153540
ACCESSION NUMBER: 0001209191-19-040985
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190703
DATE AS OF CHANGE: 20190703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLD DANIEL P PHD
CENTRAL INDEX KEY: 0001288233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 19941753
MAIL ADDRESS:
STREET 1: 10445 PACIFIC CENTER CT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTER DRIVE
STREET 2: SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-792-6300
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTER DRIVE
STREET 2: SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-01
0
0001262104
MEI Pharma, Inc.
MEIP
0001288233
GOLD DANIEL P PHD
C/O MEI PHARMA, INC.
3611 VALLEY CENTRE DRIVE, SUITE 500
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
2.52
2019-07-01
4
A
0
680000
0.00
A
2029-07-01
Common Stock
680000
680000
D
One-quarter of such Options shall vest on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
/s/ Brian G. Drazba, as attorney in fact
2019-07-01